{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:55:40Z","timestamp":1784811340695,"version":"3.55.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.2169\/internalmedicine.5615-25","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:07:55Z","timestamp":1750874875000},"page":"322-326","source":"Crossref","is-referenced-by-count":1,"title":["Limbic Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review"],"prefix":"10.2169","volume":"65","author":[{"given":"Hiromi","family":"Kaneko","sequence":"first","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Oita University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruaki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Oita University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Yabuuchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Oita University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhito","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Oita University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oita Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Oita University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine, Oita University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Reindl M, Di Pauli F, Rost\u00e1sy K, Berger T. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 9: 455-461, 2013.","DOI":"10.1038\/nrneurol.2013.118"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140: 3128-3138, 2017.","DOI":"10.1093\/brain\/awx276"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Marignier R, Hacohen Y, Cobo-Calvo A, et al. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20: 762-772, 2021.","DOI":"10.1016\/S1474-4422(21)00218-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kaneko K, Sato DK, Nakashima I, et al. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications. J Neurol Neurosurg Psychiatry 89: 927-936, 2018.","DOI":"10.1136\/jnnp-2018-317969"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Cobo-Calvo A, Ruiz A, Maillart E, et al.; OFSEP and NOMADMUS Study Group. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology 90: e1858-e1869, 2018.","DOI":"10.1212\/WNL.0000000000005560"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Budhram A, Mirian A, Le C, Hosseini-Moghaddam SM, Sharma M, Nicolle MW. Unilateral cortical FLAIR-hyperintense lesions in Anti-MOG-associated encephalitis with seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome. J Neurol 266: 2481-2487, 2019.","DOI":"10.1007\/s00415-019-09440-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ogawa R, Nakashima I, Takahashi T, et al. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4: e322, 2017.","DOI":"10.1212\/NXI.0000000000000322"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lee WJ, Kwon YN, Kim B, et al. MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes. J Neurol Neurosurg Psychiatry 94: 102-112, 2023.","DOI":"10.1136\/jnnp-2022-330074"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol 22: 268-282, 2023.","DOI":"10.1016\/S1474-4422(22)00431-8"},{"key":"10","unstructured":"10. Armangue T, Oliv\u00e9-Cirera G, Mart\u00ednez-Hernandez E, et al. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol 19: 234-246, 2020."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takasone K, Usuda M, Yoshinaga T, Sekijima Y. Limbic encephalitis with anti-myelin oligodendrocyte glycoprotein antibody. Intern Med 59: 1465-1466, 2020.","DOI":"10.2169\/internalmedicine.4216-19"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Uchigami H, Arai N, Sekiguchi M, et al. Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: a case report. Mult Scler Relat Disord 38: 101500, 2020.","DOI":"10.1016\/j.msard.2019.101500"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Horita T, Inoue T, Kuki I, et al. A case of bilateral limbic and recurrent unilateral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody positivity. Brain Dev 44: 254-258, 2022.","DOI":"10.1016\/j.braindev.2021.10.011"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lei X, Guo S, Cui S, Pu Y, Zhang A, He D. Clinical profile and treatment outcome in MOGAD: a single-center case-series study in Guiyang, China. Front Neurol 13: 830488, 2022.","DOI":"10.3389\/fneur.2022.830488"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15: 391-404, 2016.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92: 757-768, 2021.","DOI":"10.1136\/jnnp-2020-325300"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Oyanguren B, S\u00e1nchez V, Gonz\u00e1lez FJ, et al. Limbic encephalitis: a clinical-radiological comparison between herpetic and autoimmune etiologies. Eur J Neurol 20: 1566-1570, 2013.","DOI":"10.1111\/ene.12249"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123: 1481-1494, 2000.","DOI":"10.1093\/brain\/123.7.1481"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sarton B, Jaquet P, Belkacemi D, et al. Assessment of magnetic resonance imaging changes and functional outcomes among adults with severe herpes simplex encephalitis. JAMA Netw Open 4: e2114328, 2021.","DOI":"10.1001\/jamanetworkopen.2021.14328"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Tokumoto K, Nishida T, Kawaguchi N, Kaneko K, Takahashi T, Takahashi Y. Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: a case report and literature review. Seizure 98: 13-18, 2022.","DOI":"10.1016\/j.seizure.2022.04.001"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5615-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:33:31Z","timestamp":1768620811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/2\/65_5615-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5615-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"article-number":"5615-25"}}